<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1401244709
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.9
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        42.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AL RAZI PHARMA INDUSTRIES FACTORY LTD" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AL RAZI PHARMA INDUSTRIES FACTORY LTD
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2312]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL RAZI PHARMA INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AL RAZI PHARMA INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05XA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>0.9% Sodium Chloride Injection is a clear colorless to solution of Sodium Chloride in water. The solution is stored in a sealed flexible Polyethylene bottle.</p><p>0.9% Sodium Chloride Injection helps to maintain the correct balance of fluid in and around the body&rsquo;s cells and tissues. Sodium chloride infusions are given to add water to tissues which are dehydrated and to help to restore the normal salt balance.</p><p>0.9% Sodium Chloride Injection may be given alone but may be given with other medicines added.</p><p>&nbsp;Sodium Chloride Injection will be given to you in hospital by a doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <table border="0" cellspacing="0" cellpadding="0" dir="ltr" style="width:970px"><tbody><tr><td style="vertical-align:top; width:970px"><p style="text-align:left"><strong>You must NOT be given this solution if you have:</strong></p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An allergy to Sodium Chloride or any of the other ingredients.</p><p style="text-align:left"><strong>Take Special Care with 0.9 % Sodium Chloride Injection:</strong></p><p style="text-align:left"><strong>Talk to your doctor or nurse if you:</strong></p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have heart failure, cardio-pulmonary disease, kidney problems, high blood pressure, liver disease, or edema (swelling).</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have high serum levels of sodium (&ldquo;hypernatremia&rdquo;).</p></td></tr><tr><td style="vertical-align:top; width:970px"><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have pre-eclampsia of pregnancy.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are receiving drugs which may increase sodium retention.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are very young or elderly.</p><p style="text-align:left"><strong>Using other Medicines, Herbal or Dietary Supplements:</strong></p><p style="text-align:left">Tell your doctor if you are taking or have recently taken any other medicines.</p><p style="text-align:left"><strong>0.9 % Sodium Chloride Injection USP with Food and Drink:</strong></p><p style="text-align:left">There are no known interactions with food or drink.</p><p style="text-align:left"><strong>Pregnancy and Breast-Feeding:</strong></p><p style="text-align:left">If you are pregnant or breast-feeding, or think you may be pregnant or are planning to have a baby, ask your doctor for advice before being given this medicine.</p><p style="text-align:left"><strong>Driving and Using Machines:</strong></p><p style="text-align:left">0.9% Sodium Chloride Injection USP has no influence on the ability to drive and use machines.</p><p style="text-align:left">&nbsp;</p><p style="text-align:left"><strong>&nbsp;</strong></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is administered to you by a doctor or healthcare professional in hospital.</p><p>You will receive the solution by infusion into a vein (usually in your arm), administered by a doctor or nurse. The amount and rate at which the infusion is given depends&nbsp; on your requirements.</p><p>Your doctor will check your response to the treatment by the relief of your symptoms, and will probably take samples of blood and urine for laboratory testing.</p><p><strong>If you Use more 0.9 % Sodium Chloride Injection USP than you should:</strong></p><p>It is unlikely you will be given too much solution as your doctor or nurse will be checking your response to the treatment. If you receive too much solution, the balance of some chemicals in your blood may be upset and levels of sodium chloride in your blood which can lead to dehydration of some organs of the body and to loss of potassium. If you are concerned about the volume of solution given, or are worried about any affects you notice, talk to your doctor or nurse.</p><p>If you have any further questions on the use of this medicine, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:left">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p style="text-align:left">The infusion should be stopped immediately if you experience any adverse reaction.</p><p style="text-align:left"><strong>If you are given the solution for a long time, you may notice the following:</strong></p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling, especially of the legs.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feel tired, weak, dizzy, have a headache or problems with vision.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Or a fast or irregular heartbeat.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feel sick (nausea) and have an upset stomach, loss of appetite.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drowsiness, lack of energy.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cramp or discomfort of the muscles, confusion or disorientation.</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thirst, dry mouth, dark urine.</p><p style="text-align:left">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.</p><p>Do not store above 30&deg;C.</p><p>The solution should only be used if it is clear and the container is not damaged.</p><p>It should be used immediately. For single use only. Any unused solution in the bottle must be discarded.</p><p>Do not throw away any medicines via wastewater or household waste. The doctor or nurse will dispose of this medicine. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Sodium Chloride. Each liter of solution contains 9 g Sodium Chloride. Each liter contains 154 mmol Sodium and 154 mmol Chloride.</p><p>The other ingredient is water for injection.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                0.9% Sodium Chloride Injection is a clear colorless solution. The solution for infusion is packaged in a container. 
It is Available in:
polyethylene Bottles.
Contents: 500 ml, 250 ml, 100 ml, 50 ml, 10 ml, 5 ml.
Supplied in Packs of:
20 bottles x 500 ml, 40 bottles x 250 ml, 50 bottles x 100 ml , 50 bottles x 50 ml, 100 Ampules x 10 ml and 100 Ampules x 5 ml.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AL RAZI PHARMA INDUSTRIES 2nd Industrial</p><p>City &ndash; Street No. 67 Cross 110&nbsp; Building No. 3992 Dammam Kingdom of Saudi Arabia &ldquo;KSA&rdquo; .</p><p>Tel: +966 13 8281919</p><p>Fax: &nbsp;+966 13 8251313</p><p>Website: www.alrazi-pharma.com</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">كلوريد الصوديوم 0.9% محلول نقي ،عديم اللون من كلوريد الصوديوم في الماء . يتم تخزينه في عبوات بولي ايثيلين مختومة.</p><p dir="RTL">المحلول يساعد في الحفاظ على التوازن الصحيح للسوائل داخل وحول الخلايا والأنسجة في الجسم. يتم إعطاء المحلول لتعويض الماء في الأنسجة والمساعدة في استعادة التوازن الملحي.</p><p dir="RTL">يمكن إعطاء محلول كلوريد الصوديوم وحده ، كما يمكن أن يعطى مع أدوية أخرى مضافة. سيتم إعطاء المحلول لك في المستشفى من قبل الطبيب أو الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تستخدم محلول كلوريد الصوديوم الوريدي 0.9% إذا كان لديك<strong> :</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حساسية من كلوريد الصوديوم أو أي من المكونات الأخرى.</p><p dir="RTL"><u>إحتياطات خاصة بمحلول كلوريد الصوديوم الوريدي 0.9%</u></p><p dir="RTL">تحدث إلى طبيبك أو الممرضة إذا كنت:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعاني من قصور في القلب، أمراض القلب والرئتين، مشاكل في الكلى ،ارتفاع ضغط الدم، أمراض الكبد، أو تورم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعاني من ارتفاع معدل الصوديوم في الدم (&quot;فرط الصوديوم في الدم&quot;).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعاني من تسمم الحمل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ممن يتلقون الأدوية التي قد تزيد من احتباس الصوديوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الأطفال أو كبار السن.</p><p dir="RTL"><u>إستخدام أدوية أخرى ، المكملات العشبية أو الغذائية</u><strong> </strong></p><p dir="RTL">أخبر طبيبك إذا كنت تأخذ أو اتخذت مؤخرا أي أدوية أخرى.</p><p dir="RTL"><u>مع&nbsp; الطعام والشراب:</u><br />لا توجد تفاعلات مسجلة مع الطعام أو الشراب.</p><p dir="RTL"><u>الحمل والرضاعة الطبيعية</u><u>:</u><br />أخبري طبيبك إذا كنت حاملا أو ترضعين رضاعة طبيعية، أو تعتقدين بأنك حامل أو تخططين لإنجاب طفل ، إسألي طبيبك للحصول على المشورة قبل إعطائك هذا الدواء.</p><p dir="RTL"><u>استخدام الآلات وقيادة السيارات</u><u>:</u></p><p dir="RTL">هذا المحلول&nbsp; ليس له تأثير على قدرتك على القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المحلول يعطى فقط في المستشفى من قبل الطبيب أو الممارسين الصحيين المتخصصين عن طريق التسريب في الوريد (غالبا في الذراع).</p><p dir="RTL">الكمية والمعدل الذي يتم إعطاءها&nbsp; تعتمد على الحالة&nbsp; الخاصة بك.</p><p dir="RTL">طبيبك سوف يتحقق من استجابتك للعلاج عن طريق تحسن الأعراض الخاصة بك، و أخذ عينات من الدم والبول لفحصها في المختبر.</p><p dir="RTL"><u>إذا استخدمت محلول كلوريد الصوديوم &nbsp;0.9% أكثر مما يجب</u></p><p dir="RTL">يجب على الطبيب أو الممرضة متابعة استجابتك للعلاج، لذلك لن تعطى اكثر من حاجتك .إذاحصل وتلقيت الكثير من المحلول، فان التوازن لبعض المواد الكيميائية في الدم قد يتغير، اضافة الى ارتفاع مستويات كلوريد الصوديوم في الدم والتي قد تؤدي الى جفاف بعض الأعضاء وفقدان البوتاسيوم. إذا كنت تشعر بالقلق إزاء حجم المحلول، أو آثاره الجانبية ، او كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، تحدث مع طبيبك أوالممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن لهذا الدواء ان يسبب آثارا جانبية، على الرغم من أن الغالبية لا تحصل لهم.</p><p dir="RTL">يجب ان يتوقف المحلول فورا اذا واجهت اي رد فعل سلبي.</p><p dir="RTL"><u>استخدام محلول كلوريد الصوديوم&nbsp; لفترة طويلة قد يؤدي إلى الأعراض التالية:</u></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التورم وخصوصا في الساقين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتعب، الضعف، الدوار، صداع أو مشاكل في الرؤية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سرعة أو عدم انتظام ضربات القلب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يشعر المريض بالغثيان ، اضطراب في المعدة، اوفقدان الشهية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخمول، ونقص الطاقة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشنج أو الم في العضلات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العطش ، جفاف الفم والبول الداكن.</p><p dir="RTL">يرجى إخبار الطبيب أو الممرضة إذا لاحظت أي اثر جانبي مدرج أو غير مدرج.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيداً عن متناول&nbsp; الاطفال .</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية الذي ذكر على الملصق&nbsp; .تاريخ انتهاء الصلاحية يشير إلى اليوم الأخير من ذلك الشهر .</p><p dir="RTL">لا تقم بتخزينه فوق 30 درجة مؤية.</p><p dir="RTL">المحلول يجب أن يستعمل فقط إذا كان شفافاً وغير معطوب الحاوية. وينبغي أن يستخدم فورا بعد إزالة الغطاء. المحلول للاستخدام مرة واحدة فقط حيث &nbsp;يجب التخلص من أي كمية غير مستخدمة.</p><p dir="RTL">يجب عدم رمي أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. سيقوم الطبيب أو الممرضة التخلص من هذا الدواء. سوف تساعد هذه التدابير لحماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي كلوريد الصوديوم.&nbsp; كل لتر يحتوي على 9 جم من كلوريد الصوديوم.</p><p dir="RTL">كل لتر يحتوي على 154 مليمول صوديوم و 154 مليمول كلوريد.</p><p dir="RTL">العنصر الآخر الوحيد هو الماء المعد للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL"><u>كيف يبدو محلول كلوريد الصوديوم الوريدي وماهي محتويات العبوة</u></p><p dir="RTL">هو محلول نقي، عديم اللون. معبأ في عبوات بولي ايثيلين مغلقة ،متوفر بحجم &nbsp;5مل ,10 &nbsp;مل , 50 مل &nbsp;, 100 مل , 250 مل , 500 مل .</p><p>حجم الكرتون:</p><p>&nbsp;&nbsp;500 مل&nbsp; في 20 عبوة&nbsp;</p><p dir="RTL">و 250 مل&nbsp; في 40 عبوة</p><p dir="RTL">و 100 مل&nbsp; في 50 عبوة</p><p dir="RTL">و 50 مل&nbsp; في 50 عبوة</p><p dir="RTL">و 10 مل&nbsp; في 100 أمبولة&nbsp; &nbsp;</p><p dir="RTL">و 5&nbsp;مل&nbsp; في 100 أمبولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مصنع شركة الرازي للصناعات الدوائية</p><p dir="RTL">&ndash; المملكة العربية السعودية &ndash; الدمام &ndash; المدينة الصناعية الثانية .</p><p dir="RTL">ص.ب 3992 &ndash; الدمام 34332-6963 .</p><p dir="RTL">ت&nbsp;&nbsp;&nbsp; : 1919 828 13 966+</p><p dir="RTL">فاكس: 1313 828 13 966+</p><p dir="RTL">الموقعالإلكتروني: www.alrazi-pharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            


04/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                0.9% Sodium Chloride Injection USP.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium Chloride: 9 g/L
Each ml contains 9 mg Sodium Chloride.
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.
Osmolarity 308 mOsmol/l (approx.).
mmol/l:	
Na+ : 154 
Cl-: 154.
pH: 4.5 – 7.0.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>0.9% Sodium Chloride Injection USP is of value as a source of water and electrolytes and is indicated for replenishing fluid and for restoring and maintaining the concentrations of sodium and chloride ions.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>It may also be used as a vehicle for the reconstitution and administration of intravenous medications.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><u>Posology:</u></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Adults, Older People and Children:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Doses may be expressed in terms of mEq or mmol of sodium, mass of sodium, or mass of sodium salt (1 g NaCl = 394 mg, 17.1 mEq or 17.1 mmol of Na and Cl).</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>The dosage, rate and duration of administration is to be individualised as determined by several factors including age, weight, clinical condition, concomitant treatment and in particular the patient&#39;s hydration state, clinical and laboratory response to treatment. Fluid balance and plasma electrolyte concentrations must be monitored during treatment.</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><u>Recommended Dosage:</u></p></td></tr><tr><td style="vertical-align:top"><p>The recommended dosage for treatment of isotonic extracellular dehydration and sodium depletion is:</p></td></tr><tr><td style="vertical-align:top"><p>&bull;&nbsp; For adults: 500 ml to 3 liters/24h.</p></td></tr><tr><td style="vertical-align:top"><p>For babies and children: 20 to 100 ml per 24h and per kg of body weight, depending of the age and the total body mass.</p></td></tr><tr><td style="vertical-align:top"><p>The recommended dosage when used as a vehicle or diluent ranges from 50 to 250 ml per dose of medicinal product to be administered.</p></td></tr><tr><td style="vertical-align:top"><p>When Sodium Chloride 0.9 % is used as a diluent for injectable preparations of other drugs, the dosage and the infusion rate will also be dictated by the nature and the dose regimen of the prescribed drug.</p></td></tr><tr><td style="vertical-align:top"><p><u>Method of Administration:</u></p></td></tr><tr><td style="vertical-align:top"><p>The solution is for administration by intravenous infusion through a sterile and non-pyrogenic administration set, using aseptic technique. The equipment should be primed with the solution in order to prevent air entering the system.</p></td></tr><tr><td style="vertical-align:top"><p>The product should be inspected visually for particulate matter and discoloration prior to administration. Do not administer unless solution is clear, free from visible particles and the seal is intact.</p></td></tr><tr><td style="vertical-align:top"><p>Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of the solution. Administer immediately following the insertion of infusion set.</p></td></tr><tr><td style="vertical-align:top"><p>Do not connect flexible plastic containers in series in order to avoid air embolism due to possible residual air contained in the primary container. Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration. Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.</p></td></tr><tr><td style="vertical-align:top"><p>Additives may be introduced before infusion or during infusion through the injection site.</p></td></tr><tr><td style="vertical-align:top"><p>For information on incompatibilities and preparation of the product (with additives), please see sections 6.2 and 6.6.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This product must be used with caution in patients with an impaired ability to handle sodium such as organic heart disease especially with a history of congestive heart failure, patients with renal insufficiency, cirrhosis of the liver, cardiopulmonary diseases or patients receiving salt retaining steroids.
When used in conjunction with cell separator procedures, the solution is contraindicated in those patients where adequate anticoagulation cannot be achieved.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Fluid balance/renal function:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Use in patients with (severe) renal impairment:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Sodium Chloride 0.9% should be administered with particular caution to patients with or at risk of severe renal impairment. In such patients administration of Sodium Chloride 0.9% may result in sodium retention. (See &ldquo;Use in patients at risk for sodium retention, fluid overload and oedema&rdquo; below, for additional considerations.)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Risk of fluid and/or solute overload and electrolyte disturbances:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Depending on the volume and rate of infusion, intravenous administration of Sodium Chloride 0.9% can cause:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fluid and/or solute overload resulting in overhydration/hypervolemia and, for example, congested states, including central and peripheral oedema.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clinically relevant electrolyte disturbances and acid-base imbalance.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>In general, the risk of dilutional states (retention of water relative to sodium) is inversely proportional to the electrolyte concentrations of Sodium Chloride 0.9% and its additions. Conversely, the risk of solute overload causing congested states (retention of solute relative to water) is directly proportional to the electrolyte concentrations of Sodium Chloride 0.9% and its additions.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Special clinical monitoring is required at the beginning of any intravenous infusion. Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Use in patients at risk for sodium retention, fluid overload and oedema:</p></td></tr><tr><td style="vertical-align:top"><p>Sodium Chloride 0.9% should be used with particular caution, if at all, in patients with or at risk for:</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypernatraemia. Rapidly correcting hypernatremia once adaptation has occurred may lead to cerebral oedema, potentially resulting in seizures, permanent brain damage, or death.</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperchloraemia</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; Metabolic acidosis, which may be worsened by prolonged use of this product, especially in patients with renal impairment.</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypervolemia such as congestive heart failure and pulmonary oedema may be precipitated, particularly in patients with cardiovascular disease.</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Iatrogenic hyperchloremic metabolic acidosis (e.g., during intravenous volume</p><p>resuscitation)</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conditions that may cause sodium retention, fluid overload and oedema (central and peripheral), such as patients with</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; primary hyperaldosteronism,</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; secondary hyperaldosteronism, associated with, for example,</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypertension,</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; congestive heart failure,</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; liver disease (including cirrhosis),</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Renal disease (including renal artery stenosis, nephrosclerosis) or pre-eclampsia.</p></td></tr><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medications that may increase the risk of sodium and fluid retention, such as corticosteroids.</p></td></tr><tr><td style="vertical-align:top"><p>Infusion reactions:</p></td></tr><tr><td style="vertical-align:top"><p>Symptoms of unknown aetiology which can appear to be hypersensitivity reactions have been reported very rarely in association with infusion of Sodium Chloride 0.9 %. These have been characterized as hypotension, pyrexia, tremor, chills, urticaria, rash and pruritus. Stop the infusion immediately if signs or symptoms of these reactions develop. Appropriate therapeutic</p><p>countermeasures should be instituted as clinically indicated.</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Specific patient groups:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>The consulting physician should be experienced in this product&#39;s use and safety in these special populations that are especially sensitive to rapid changes in serum sodium levels.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rapid correction of hyponatraemia and hypernatremia is potentially dangerous (risk of serious neurologic complications). See section &ldquo;Hyponatraemia/hypernatraemia&rdquo; above.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Paediatric population:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Plasma electrolyte concentrations should be closely monitored in the paediatric population as this population may have impaired ability to regulate fluids and electrolytes.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Repeated infusions of sodium chloride should therefore only be given after determination of the serum sodium level.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Geriatric population:</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>When selecting the type of infusion solution and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are generally more likely to have cardiac, renal, hepatic, and other diseases or concomitant drug therapy.</p><p>For information on preparation of the product and additives, please see section 6.6.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>As with any prolonged intravenous infusion, venous irritation and thrombophlebitis may occur</p><p>at the injection site.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>When used in conjunction with cell separator procedures, there is a risk of air embolism or haemolysis. A donor should not be subjected to this procedure more frequently than once in a</p><p>48 hour period, twice in 7 days or 24 times a year.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Caution is advised in patients treated with lithium. Renal sodium and lithium clearance may be increased during administration of Sodium Chloride 0.9%. Administration of Sodium Chloride 0.9% may result in decreased lithium levels.</p></td></tr><tr><td style="vertical-align:top"><p>Corticoids/Steroids and carbenoxolone, are associated with the retention of sodium and water (with oedema and hypertension).</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no adequate data from the use of Sodium Chloride 0.9% in pregnant or lactating women. The physician should carefully consider the potential risks and benefits for each specific patient before administering Sodium Chloride 0.9%.</p><p>Caution is advised with patients with pre-eclampsia (See Section 4.4. Special warnings and precautions for use).</p><p>When a medicinal product is added, the nature of the drug and its use during pregnancy and lactation has to be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies have been conducted on the influence of 0.9% Sodium Chloride on the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Thrombophlebitis of the chosen vein is always a possibility with intravenous infusion. Extravasation of the solution may cause oedema and skin necrosis.</p><p><img alt="" width="506" height="270" src="data:image/jpeg;base64,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" /></p><p>&nbsp;</p><p>The following adverse reactions have not been reported with this product but may occur: Hypernatremia (e.g. when administered to patients with nephrogenic diabetes insipidus or high nasogastric output)&nbsp;Hyperchloremic metabolic acidosis Hyponatraemia, which may be symptomatic. Hyponatraemia may occur when normal free water excretion is impaired. (e.g. SIADH or postoperative)</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>General adverse effects of sodium excess are described in section 4.9 Overdose.</p></td></tr><tr><td style="vertical-align:top"><p>Additives:</p></td></tr><tr><td style="vertical-align:top"><p>When Sodium Chloride 0.9% is used as a diluent for injectable preparations of other drugs, the nature of additives will determine the likelihood of any other undesirable effect.</p></td></tr><tr><td style="vertical-align:top"><p>If an adverse event occurs the patient should be evaluated and appropriate counter measures be started, if needed the infusion should be stopped. The remaining part of the solution should be kept for investigation if deemed necessary.</p></td></tr><tr><td style="vertical-align:top"><p>When used in conjunction with cell separator procedures, reactions commonly experienced in routine blood collection such as syncope, vomiting and hyperventilation may occur. Individuals donating for the first time may be predisposed to these symptoms due to</p><p>psychological factors. Reactions unique to apheresis collection procedures may also occur</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0" style="width:809px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top; width:789px"><p><strong>Note: </strong>To report any side effects please contact;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top; width:789px"><p>National Pharmacovigilance and Drug Safety Centre (NPC) Fax: +966-11-205-7662</p><p>Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>Toll free Phone: 8002490000 E-mail: npc.drug@sfda.gov.sa Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Symptoms include restlessness, weakness, thirst, reduced salivation and lachrymation, swollen tongue, flushing of the skin, pyrexia, dizziness, headache, oliguria, hypotension, tachycardia, delerium, hyperpnoea and respiratory arrest. When overdose occurs measures should be taken to correct the fluid and electrolyte imbalance. An excess of sodium can be removed by the injection of a diuretic.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>General adverse effects of sodium excess in the body include nausea, vomiting, diarrhea, abdominal cramps, thirst, reduced salivation and lacrimation, sweating, fever, tachycardia, hypertension, renal failure, peripheral and pulmonary oedema, respiratory arrest, headache, dizziness, restlessness, irritability, weakness, muscular twitching and rigidity, convulsions, coma, and death.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>An excessive volume of Sodium Chloride 0.9% may lead to hypernatraemia (which can lead to CNS manifestations, including seizures, coma, cerebral oedema and death) and sodium</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>overload (which can lead to central and/or peripheral oedema) and should be treated by an attending specialized physician.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Excess chloride in the body may cause a loss of bicarbonate with an acidifying effect.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>When Sodium Chloride 0.9% is used as a diluent for injectable preparations of other drugs, the signs and symptoms of over infusion will be related to the nature of the additives being used. In the event of accidental over infusion, treatment should be discontinued and the patient should be observed for the appropriate signs and symptoms related to the drug administered.</p><p>The relevant and supportive measures should be provided as necessary.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>ATC code: B05XA03.</p></td></tr><tr><td style="vertical-align:top"><p>Pharmacotherapeutic group: &ldquo;Other IV Solution Additives&rdquo;</p></td></tr><tr><td style="vertical-align:top"><p>Sodium Chloride 0.9% intravenous infusion is an isotonic solution, with an approximate osmolarity of 308 mOsm/L.</p></td></tr><tr><td style="vertical-align:top"><p>The pharmacodynamics properties of the solution are those of the sodium and chloride ions in maintaining the fluid and electrolyte balance. Ions, such as sodium, circulate through the cell membrane, using various mechanisms of transport, among which is the sodium pump (Na-K- ATPase). Sodium plays an important role in neurotransmission and cardiac electrophysiology,</p><p>and also in its renal metabolism.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium is predominantly excreted by the kidney, but there is extensive renal reabsorption.</p><p>Small amounts of sodium are lost in the faeces and sweat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety of sodium chloride in animals is not relevant in view of its presence as a normal component in animal and human plasma.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:809px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top; width:789px"><p>Water for Injections</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-right:80px">As with all parenteral solutions compatibility of the additives with the solution must be assessed before addition. In the absence of compatibility studies, this solution must not be mixed with other medicinal products. Those additives known to be&nbsp; incompatible should not&nbsp; be Used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Month.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" dir="ltr" style="width:807px"><tbody><tr><td style="vertical-align:top; width:807px"><p style="text-align:justify">Do not store above 30&deg;C.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>The container is made of Low Density-Polyethylene (LDPE) The primary packaging material Low Density-Polyethylene (LDPE) is used for several years in the pharmaceutical industry for the primary packaging of comparable drug products. The material is known for its</p><p>compatibility with the ingredients of the drug product.</p></td></tr><tr><td style="vertical-align:top"><p>The container material, LD (Low Density)-polyethylene meets the requirements of the European Pharmacopoeia (Ph. Eur. 3.2.2).</p></td></tr><tr><td style="vertical-align:top"><p>The material shows a density of 0.9%26-0.9%30 g/cm3.The container can be sterilised at temperatures between 106-112 &deg;C.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:801px"><tbody><tr><td style="vertical-align:top; width:801px"><p>For single use only. Do not use unless the solution is clear and the container undamaged.</p><p>&nbsp;Discard any unused solution.</p></td></tr><tr><td style="vertical-align:top; width:801px"><p>&nbsp;Any unused product or waste material should be disposed of in accordance with local requirements.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Addition of medicinal products:</strong></p></td></tr><tr><td style="vertical-align:top"><p>Confirm additive compatibility before use.</p></td></tr><tr><td style="vertical-align:top"><p>Clean the injection site using antiseptic solution.</p></td></tr><tr><td style="vertical-align:top"><p>Carefully introduce the sterile needle into the sterile chamber in the injection site, attach the</p><p>needle to the container with the medicinal product, introduce the needle through the second membrane into the bag and inject the medicine. Carefully withdraw the needle.</p></td></tr><tr><td style="vertical-align:top"><p>Mix thoroughly with the solution. Use immediately.</p></td></tr></tbody></table></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AL RAZI PHARMA INDUSTRIES
, Building No.3992 Street No 67.Cross 110,2nd Industrial City,
Dammam Kingdom of Saudi Arabia – 
Tel: +966138281919, Fax: +966138251414, 
Website: www.alrazi-pharma.com


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	03/2019.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>